Prostaglandin E1 suppresses low density lipoprotein receptor activity and cholesterol synthesis in human mononuclear leukocytes.
Krone
W
W
Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg, F.R.G.
Klass
A
A
Nägele
H
H
Behnke
B
B
Greten
H
H
D000085:Acetates / Q000097:blood; D000527:Alprostadil / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood*; D003505:Cyclodextrins / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism*; D011973:Receptors, LDL / Q000187:drug effects / Q000378:metabolism*; D047391:alpha-Cyclodextrins
D000085:Acetates; D003505:Cyclodextrins; D011973:Receptors, LDL; D047391:alpha-Cyclodextrins; D003994:Bucladesine; D002784:Cholesterol; D000527:Alprostadil; C032613:alpha-cyclodextrin